From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis

scientific article

From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/MCP.M300094-MCP200
P698PubMed publication ID14593079

P2093author name stringYan Li
Rong Zeng
Hong-Yang Wang
Qi-Chang Xia
Zhao-You Tang
Jia-Rui Wu
Sheng-Long Ye
Shi-Jian Ding
Bo Tian
Ye-Xiong Tan
Xiao-Xia Shao
Man-Rong Jiang
Ying-Kun Liu
P2860cites workOnset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: defining a potential role for keratin 16Q24672122
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide GelsQ27860531
The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cellsQ28262541
A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometryQ30660638
Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequenceQ30724074
Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentialsQ33200413
The prognostic molecular markers in hepatocellular carcinomaQ34668320
Expression of complete keratin filaments in mouse L cells augments cell migration and invasionQ36288957
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancerQ37340550
New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasisQ38273658
Elevation of cytokeratin 19 fragment in serum in patients with hepatoma: its clinical significanceQ40821157
Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometryQ40853089
Keratin 19 downregulation by oral squamous cell carcinoma lines increases invasive potentialQ40947817
Role of intermediate filaments in migration, invasion and metastasisQ41349193
Cytokeratin expression during AFB1-induced carcinogenesisQ41730030
P433issue1
P921main subjecthepatocellular carcinomaQ1148337
overexpressionQ61643320
P304page(s)73-81
P577publication date2003-10-30
P1433published inMolecular & Cellular ProteomicsQ6895932
P1476titleFrom proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis
P478volume3

Reverse relations

cites work (P2860)
Q43634441Alteration in apoptosis and cell cycle by celecoxib and/or fish oil in 7,12-dimethyl benzene (α) anthracene-induced mammary carcinogenesis
Q36732510Analysis of phenotype-genotype connection: the story of dissecting disease pathogenesis in genomic era in China, and beyond
Q36111028Application of proteomics in the study of tumor metastasis
Q57422139CK19 and CD99 Immunoexpression Profile in Goblet Cell (Mucin-Producing Neuroendocrine Tumors) and Classical Carcinoids of the Vermiform Appendix
Q35258032CK19 is a sensitive marker for yolk sac tumours of the testis
Q40022052Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma
Q42207466Changes in glucose-6-phosphate dehydrogenase expression results in altered behavior of HBV-associated liver cancer cells
Q48118614Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significance
Q53386792Comprehensive profiling of metastasis-related proteins in paired hepatocellular carcinoma cells with different metastasis potentials.
Q53898691Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology.
Q33751830Coronin-1C is a novel biomarker for hepatocellular carcinoma invasive progression identified by proteomics analysis and clinical validation
Q54444216CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
Q87677698Cytokeratin 7/19 expression in N-diethylnitrosamine-induced mouse hepatocellular lesions: implications for histogenesis
Q38673577Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis
Q33275840Detection of the inferred interaction network in hepatocellular carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online).
Q42318305Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
Q33531276Differential proteomic analysis of a highly metastatic variant of human breast cancer cells using two-dimensional differential gel electrophoresis.
Q39653490Epidermal growth factor induces cytokeratin 19 expression accompanied by increased growth abilities in human hepatocellular carcinoma
Q37462365Experimental models of hepatocellular carcinoma: developments and evolution
Q36110393Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma
Q57149606Expression of bile duct transcription factor HNF1β predicts early tumor recurrence and is a stage-independent prognostic factor in hepatocellular carcinoma
Q35745018Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma
Q82589019Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma
Q92891477Expression pattern of placenta specific 8 and keratin 20 in different types of gastrointestinal cancer
Q81120947Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resection
Q39562944FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma
Q37277185Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Q33556895Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness
Q36638176Hepatic progenitor cells in human liver tumor development
Q34744836Hepatitis B virus infection: a favorable prognostic factor for intrahepatic cholangiocarcinoma after resection
Q35531664Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts
Q51775017Hepatocellular carcinoma in individuals with HBV infection or HBV-HCV co-infection in a low endemic country.
Q34633249Hepatocellular carcinoma: insight from animal models
Q53467129Histopathological classification of hepatocellular carcinoma.
Q34651211Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma.
Q50937876ITMSQ: A software tool for N- and C-terminal fragment ion pairs based isobaric tandem mass spectrometry quantification.
Q36946778Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers
Q37084179Influence of reproductive tract obstruction on expression of epididymal proteins and their restoration after patency
Q54719345Inhibitory effect of phytoglycoprotein (24 kDa) on hepatocarcinogenesis in N-nitrosodiethylamine-treated ICR mice.
Q64928988Intermediate Filaments as Effectors of Cancer Development and Metastasis: A Focus on Keratins, Vimentin, and Nestin.
Q33711578Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours
Q38725581Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.
Q33997118Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Q53398114MRI features of hepatocellular carcinoma expressing progenitor cell markers.
Q35619951MRI features of hepatocellular carcinoma related to biologic behavior
Q34164408MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma
Q39038889Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma
Q40125882Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases
Q38584282Proteome Analyses of Hepatocellular Carcinoma
Q33290708Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues
Q39642084Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray
Q38475218Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins.
Q30157380Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells
Q39515451Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma
Q33268322Proteomic profiling identifies breast tumor metastasis-associated factors in an isogenic model
Q37769478Proteomics in China: ready for prime time
Q39915284Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC.
Q42784778Quantitative proteomic analysis of a paired human liver healthy versus carcinoma cell lines with the same genetic background to identify potential hepatocellular carcinoma markers
Q39049068RNA interference targeting human integrin α6 suppresses the metastasis potential of hepatocellular carcinoma cells
Q37474142Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria
Q35056704Rho kinase phosphorylation promotes ezrin-mediated metastasis in hepatocellular carcinoma
Q36015365Risk Factors for Distant Metastasis in Patients with Minimally Invasive Follicular Thyroid Carcinoma
Q63641946Role of p53 and β-catenin Mutations in Conjunction with CK19 Expression on Early Tumor Recurrence and Prognosis of Hepatocellular Carcinoma
Q38704948Screening and identification of the tumor-associated antigen CK10, a novel potential liver cancer marker
Q41715032Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma
Q40264763Serum CYFRA 21-1 level reflects hepatocellular carcinoma metastasis: study in nude mice model and clinical patients
Q34501851Serum tumor markers for detection of hepatocellular carcinoma
Q40555471Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics
Q24797522System-based proteomic analysis of the interferon response in human liver cells
Q35710117TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer
Q28071619The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma
Q64060035The Role of MicroRNAs in Hepatoblastoma Tumors
Q35923530The keratin cytoskeleton in liver diseases
Q40694579The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma
Q35582077Time-dependent effect of hypoxia on tumor progression and liver progenitor cell markers in primary liver tumors
Q81083940Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor
Q46693261Two-dimensional differential gel electrophoresis/analysis of diethylnitrosamine induced rat hepatocellular carcinoma
Q35847118Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration

Search more.